AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma
Recently, AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma for the co-developing orphan GPCR drug discovery pipeline.
Read moreWe are the Intelligent Molecule Creators. We aim at discovering and developing new drug molecules to treat major human disorders and diseases including those against infections, cancers, Alzheimer's disease, diabetes, aging and others. We primarily focus on G protein-coupled receptors (GPCRs) related signalling pathway.
AlphaMol accelerates GPCR drug discovery in an ultimately efficient way
The position for senior medicinal chemist requests a M.S. (10-15 years) or PhD (8-10 years) in medicinal chemistry, with extensive drug discovery experience in industry. The successful... Reed More
Ph.D. or MS after 5 years of graduation in pharmacology, Immunology, Cell Biology, Molecular Biology or related field with 5+ years or M.S. with 10+ years of relevant experience... Reed More
Recently, AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma for the co-developing orphan GPCR drug discovery pipeline.
Read moreThe paper enttiled "Advancing Drug Discovery via Artificial Intelligence" by the team member of AlphaMol has been in the list of Highly Cited Article (HCA). The total citation of this work is over 310 times by April 2023.
Read moreBy resolving the 3D structure of this important target Panx2 coupled with computational simulations, the molecular mechanisms were illuminated which could guide Panx2-based drug discovery for brain cancer.
Read moreAlphaMol attended BioEuro 2022 in Leipzig, Germany and made collaborations with different partners.
Read moreThe cofounders of AlphaMol Dr. Horst Vogel and Dr. Shuguang Yuan are among World’s Top 2% Scientists in the 2022 list.
Read moreAlphaMol presented in the international GPCR conference
Read moreThe XXVIII Symposium on "Bioinformatics and Computer-Aided Drug Discovery--Emerging Challenges and Opportunities for In Silico Drug Discovery " was held online on May 24 - 26.
Read moreAlphaMol scientists developed a new computational algorithm for physical property predictions.
Read moreAlphaMol Science made breakthrough in orphan GPCR new drug discovery via innovative computational methods.
Read more
© 2023 All rights are reserved by AlphaMol Science Ltd